Shockwave Medical (SWAV) Tops Q4 EPS by 26c

Shockwave Medical (NASDAQ: SWAV) reported Q4 EPS of $0.34, $0.26 better than the analyst estimate of $0.08. Revenue for the quarter came in at $84.2 million versus the consensus estimate of $75.43 million.

GUIDANCE:

Shockwave Medical sees FY2022 revenue of $405-425 million, versus the consensus of $386.73 million.

For earnings history and earnings-related data on Shockwave Medical (SWAV) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• HSBC Upgrades Blue Star Limited (BLSTR:IN) to Buy
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c